Home Weight loss (GLP-1) By state Massachusetts
Massachusetts GLP-1 Cuts: GIC, MassHealth: 8 programs ship to MA
2026 was the year Massachusetts plans pulled back. Blue Cross Blue Shield of Massachusetts, the state employee plan and MassHealth all stopped routine weight-loss GLP-1 coverage within six months. If you lost coverage this year, you are far from alone, and there are cheaper ways to keep going. The lowest price we found from a program that ships to Massachusetts: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.
Massachusetts at a glance
- Massachusetts Medicaid
- Does not cover for weight loss
- State employee plan
- Does not cover for weight loss
- Adults with obesity
- 27% (2025)
- Programs we compare that ship to MA
- 8 of 22
Online GLP-1 programs for Massachusetts, cheapest first
Programs that ship to Massachusetts. Prescribed online by a licensed clinician; medication and delivery included.
How we pick and check programs
Our pick for November 2026

A daily oral GLP-1 plan. No needles, no injections
Compounded semaglutide in Massachusetts: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | LttlCheapest | $89/mo 12-month plan | $99 / 4 wks | VisitLttl |
| 2 | BetterMe Rx | $99/mo 12-month plan | $199/mo | VisitBetterMe Rx |
| 3 | Refills | $99/mo | $99 / 4 wks | VisitRefills |
| 4 | Direct Meds | $297/mo | $297/mo | VisitDirect Meds |
| 5 | Gala | From $69/mo starting price, plan length not stated | Not stated | VisitGala |
| 6 | TrimRx | From $349/mo starting price, plan length not stated | Not stated | VisitTrimRx |
Compounded tirzepatide in Massachusetts: lowest monthly price
| # | Program | Lowest price | Month to month | Link |
|---|---|---|---|---|
| 1 | MaximusCheapest | $99.99/mo 12-month plan | Not offered | VisitMaximus |
| 2 | Lttl | $139/mo 12-month plan | $149 / 4 wks | VisitLttl |
| 3 | BetterMe Rx | $159/mo 12-month plan | $249/mo | VisitBetterMe Rx |
| 4 | Refills | $159/mo | $159 / 4 wks | VisitRefills |
| 5 | Direct Meds | $399/mo | $399/mo | VisitDirect Meds |
| 6 | Gala | From $99/mo starting price, plan length not stated | Not stated | VisitGala |
| 7 | TrimRx | From $279/mo starting price, plan length not stated | Not stated | VisitTrimRx |
- Low month-to-month#1
Up to $140 off your first monthCompounded semaglutide for $99, month to month
Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month planVisit Lttl Read our Lttl review - Pills or shots#2
Semaglutide from $99/moChoose weekly shots or daily tablets; shots from $99/mo on the 12-month plan
Semaglutide shots from$99/moon the 12-month plan; $199 month to monthVisit BetterMe Rx Read our BetterMe Rx review - No contract#3
Fall sale: 40% offCompounded semaglutide as low as $99 a month
Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale4.2 on Trustpilot1,779 reviews ·Visit Refills Read our Refills review - Low-cost tirzepatide#4
Same price at every doseCompounded tirzepatide from $99.99 a month
Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months4.4 on Trustpilot1,106 reviews ·Visit Maximus Read our Maximus review - Delivery in 1-2 days#5
Fall sale: $150 offSame price at every dose, at your door in 1-2 days
Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"4.5 on Trustpilot17,724 reviews ·Visit Direct Meds Read our Direct Meds review
3 more programs are in the price tables above.
Three coverage cuts in one year
It started in January. From January 1, 2026, as members renewed, Blue Cross Blue Shield of Massachusetts began covering GLP-1s only for type 2 diabetes. Obesity coverage now applies only when an employer buys a rider. Then, on July 1, the Group Insurance Commission stopped covering GLP-1s prescribed only for weight loss for state and many municipal workers. GIC staff said about 22,000 members were taking them. Diabetes coverage stayed in place under both plans. If your employer is self-funded, ask HR, because those plans set their own rules.
MassHealth followed days later. Its pharmacy bulletin says weight-loss GLP-1s stopped being covered on July 3, 2026, with prior authorizations ending July 2. WBUR reported that at least 22,000 MassHealth members were affected. MassHealth still covers GLP-1s for diabetes and some other conditions. The Boston Globe reported the cut was expected to save the state about $15 million. Members who were mid-treatment had to decide quickly whether to stop or pay out of pocket.
The result is a lot of people paying cash at the same moment. Online programs licensed in Massachusetts offer compounded semaglutide and tirzepatide for a fraction of the brand-name price, and Maximus sells brand-name drugs here as well. If you are mid-treatment, compare the price at your current dose, since that is what you will actually pay each month, and ask whether the visit and shipping are included.
- MassHealth stopped covering GLP-1s used for weight loss effective July 3, 2026 (MassHealth Pharmacy Facts 276). (mass.gov)
- At least 22,000 MassHealth members were affected by the change, officials told WBUR. (wbur.org)
- The Group Insurance Commission stopped covering GLP-1s prescribed solely for weight loss on July 1, 2026. (mass.gov)
- Blue Cross Blue Shield of Massachusetts covers GLP-1s only for type 2 diabetes from January 1, 2026, unless an employer buys an obesity rider. (bluecrossma.org)
- Ending MassHealth weight-loss GLP-1 coverage was expected to save about $15 million (Boston Globe). (bostonglobe.com)
- 27.0% of Massachusetts adults had obesity in 2025, among the lowest rates in the U.S. (CDC). (cdc.gov)
- The Group Insurance Commission, which covers more than 460,000 people, voted 10-7 to drop weight-loss GLP-1 coverage; about 22,000 members used the drugs for weight loss at a cost of roughly $46 million (Boston.com). (boston.com)
- After July 1, 2026, GIC coverage continues for diabetes, for established heart disease with a BMI of 27 or more, for sleep apnea with a BMI of 30 or more, and for MASH (no BMI minimum). (mass.gov)
- Division of Insurance Filing Guidance Notice 2025-H (March 4, 2025) let insured carriers decide at their discretion whether to cover GLP-1s for non-diabetic conditions in 2026 plans. (mass.gov)
- Chapter 159 of the Acts of 2014 bars out-of-state pharmacies from dispensing sterile or complex non-sterile compounded drugs into Massachusetts without a nonresident compounding license. (malegislature.gov)
- The Massachusetts Board of Registration in Pharmacy said that from May 1, 2025, pharmacies outside the state must hold the proper Massachusetts license to dispense into it. (nabp.pharmacy)
What the GIC still pays for after its July 2026 vote
The Group Insurance Commission, which covers more than 460,000 people, voted 10-7 in early 2026 to stop paying for GLP-1s used only for weight loss. Boston.com reported that about 22,000 GIC members were using them for that purpose, at a cost of roughly $46 million. The cut took effect July 1, 2026 for members of the non-Medicare plans.
Some members still qualify. GIC said coverage continues for diabetes, for established heart disease with a BMI of 27 or more, for sleep apnea with a BMI of 30 or more, and for the liver disease MASH (no BMI minimum). The catch is paperwork: your doctor may need to file a new request showing the drug treats that condition. Vida Health no longer prescribes GLP-1s for GIC members after July 1, but its weight management support runs through December 31, 2026.
Why Boston's insurers could each make their own call
The state left this choice to carriers on purpose. In Filing Guidance Notice 2025-H, dated March 4, 2025, the Division of Insurance told insured health plans that they may, at their discretion, cover GLP-1s for non-diabetic conditions in 2026 plans, and that they must notify non-diabetic members who were taking them. Diabetes use was handled separately.
Most of the big names used that freedom to pull back. Blue Cross Blue Shield of Massachusetts moved to diabetes-only coverage as groups renewed in 2026, and Boston.com reported that Point32Health and Health New England also cut weight-loss coverage. Self-funded employers follow federal rules and can still choose to cover these drugs, which is why two neighbors on the same insurer card can get different answers.
Massachusetts' post-NECC rules for pharmacies that ship in
Massachusetts has some of the strictest compounding rules in the country, and they trace back to the 2012 fungal meningitis outbreak caused by a Framingham compounding pharmacy. Chapter 159 of the Acts of 2014 bars out-of-state pharmacies from dispensing sterile or complex non-sterile compounded drugs into the state unless they hold a Massachusetts nonresident compounding license.
For years that license did not exist in practice. The Board of Registration in Pharmacy opened nonresident licensing in December 2024 and said that, starting May 1, 2025, any pharmacy outside Massachusetts must hold the right licenses to dispense here. Before you pay a compounded GLP-1 program, ask which pharmacy fills your order and whether it holds a Massachusetts nonresident license.
GLP-1 in Massachusetts: questions
Does MassHealth still cover Wegovy or Zepbound for weight loss?
No. MassHealth ended coverage of GLP-1s used for weight loss on July 3, 2026. It still covers them for type 2 diabetes and some other conditions. Former MassHealth patients who want to continue can switch to a cash option, such as the programs compared on this page.
I'm on the GIC. Why did my weight-loss GLP-1 stop being covered?
The Group Insurance Commission ended coverage of GLP-1s prescribed solely for weight loss on July 1, 2026, to control costs. Diabetes coverage continues. GIC members who want to keep their weight-loss treatment can pay cash through an online program. Prices start well below the brand list price, and some keep one price at every dose.
Does Blue Cross Blue Shield of Massachusetts cover GLP-1s for obesity in 2026?
Only if your employer bought the obesity rider. From January 1, 2026, as plans renewed, Blue Cross Blue Shield of Massachusetts covers GLP-1s for type 2 diabetes only by default. Ask your HR team whether your group added the rider. If not, compare the cash programs below before paying the full pharmacy price.
How can I keep taking a GLP-1 in Massachusetts after losing coverage?
A cash program is one route. Maximus serves Massachusetts and sells brand-name Wegovy and Zepbound, and online programs also offer compounded semaglutide and tirzepatide at lower prices. Tell the new clinician what you take now and when your last dose was; the clinician decides the starting dose.
Are online GLP-1 programs legal in Massachusetts?
Yes. The programs on this page are ones that say on their own site that they serve Massachusetts. They ship to your home, so you skip the pharmacy line in Boston or Worcester.
Does the GIC still cover GLP-1s for sleep apnea or heart disease?
It can. After July 1, 2026, GIC coverage continues for diabetes, for established heart disease with a BMI of 27 or more, for sleep apnea with a BMI of 30 or more, and for MASH (no BMI minimum). Your doctor may need to file a new prior authorization. Weight loss alone no longer qualifies.
Can an out-of-state pharmacy ship compounded semaglutide to Massachusetts?
Only with a Massachusetts license. State law requires pharmacies outside Massachusetts to hold a nonresident license to dispense compounded sterile drugs here, and the pharmacy board has enforced licensing since May 1, 2025. Ask your program which pharmacy fills your order and confirm it is licensed in Massachusetts.
What is the cheapest GLP-1 in Massachusetts?
Compounded semaglutide from $89 a month at Lttl, which ships to Massachusetts. Tirzepatide starts at $99.99 a month.